Bullfrog AI (BFRG) Competitors $3.21 +0.19 (+6.26%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BFRG vs. ZIVO, KPTI, RANI, IMAB, ASRT, GALT, ANL, EPIX, AVTE, and ENTXShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include ZIVO Bioscience (ZIVO), Karyopharm Therapeutics (KPTI), Rani Therapeutics (RANI), I-Mab (IMAB), Assertio (ASRT), Galectin Therapeutics (GALT), Adlai Nortye (ANL), ESSA Pharma (EPIX), Aerovate Therapeutics (AVTE), and Entera Bio (ENTX). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. ZIVO Bioscience Karyopharm Therapeutics Rani Therapeutics I-Mab Assertio Galectin Therapeutics Adlai Nortye ESSA Pharma Aerovate Therapeutics Entera Bio ZIVO Bioscience (NASDAQ:ZIVO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation. Do institutionals and insiders hold more shares of ZIVO or BFRG? 12.8% of ZIVO Bioscience shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 21.5% of ZIVO Bioscience shares are held by insiders. Comparatively, 33.9% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor ZIVO or BFRG? In the previous week, Bullfrog AI had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 4 mentions for Bullfrog AI and 1 mentions for ZIVO Bioscience. ZIVO Bioscience's average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ZIVO Bioscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, ZIVO or BFRG? Bullfrog AI has higher revenue and earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZIVO Bioscience$15.85K4,903.45-$7.78M-$4.88-4.30Bullfrog AI$60K490.66-$5.36M-$0.85-3.98 Do analysts prefer ZIVO or BFRG? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZIVO Bioscience 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ZIVO or BFRG more profitable? ZIVO Bioscience's return on equity of 0.00% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets ZIVO BioscienceN/A N/A -2,240.92% Bullfrog AI N/A -141.39%-124.63% Which has more risk & volatility, ZIVO or BFRG? ZIVO Bioscience has a beta of 0.12, indicating that its share price is 88% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Does the MarketBeat Community prefer ZIVO or BFRG? ZIVO Bioscience received 99 more outperform votes than Bullfrog AI when rated by MarketBeat users. CompanyUnderperformOutperformZIVO BioscienceOutperform Votes9960.74% Underperform Votes6439.26% Bullfrog AIN/AN/A SummaryBullfrog AI beats ZIVO Bioscience on 8 of the 13 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.57M$6.89B$5.69B$9.01BDividend YieldN/A2.91%5.32%4.00%P/E Ratio-3.999.0588.1319.30Price / Sales490.66306.801,013.7874.83Price / CashN/A75.4646.0938.87Price / Book7.865.495.054.98Net Income-$5.36M$123.50M$113.45M$222.75M7 Day Performance37.40%-4.93%-1.68%-0.94%1 Month Performance59.43%-2.49%3.13%2.50%1 Year Performance-28.24%1.42%20.86%17.53% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.0675 of 5 stars$3.21+6.3%N/A-39.7%$27.36M$60,000.00-3.704Short Interest ↑News CoverageGap DownZIVOZIVO BioscienceN/A$21.24+7.3%N/A+139.4%$78.80M$30,000.00-4.3510KPTIKaryopharm Therapeutics3.8227 of 5 stars$0.62flat$5.00+703.7%-55.4%$78.50M$146.03M-0.55380Analyst ForecastRANIRani Therapeutics3.5732 of 5 stars$1.36-2.2%$11.71+761.3%-62.8%$77.91MN/A-1.28110Gap UpIMABI-Mab3.5266 of 5 stars$0.95-6.8%$8.00+741.1%-43.9%$77.52M$3.27M0.00380Short Interest ↓ASRTAssertio3.4176 of 5 stars$0.81+0.9%$3.25+301.2%+7.1%$77.34M$125.76M-1.1120Short Interest ↓Positive NewsGALTGalectin Therapeutics1.9353 of 5 stars$1.23-1.6%$11.00+794.3%-22.5%$77.20MN/A-1.689ANLAdlai Nortye1.9193 of 5 stars$2.09-1.4%$9.00+330.6%-74.2%$77.12M$5M0.00127Short Interest ↑EPIXESSA Pharma3.3422 of 5 stars$1.69-1.7%$9.50+462.1%-84.6%$75.02MN/A-2.6450Earnings ReportAVTEAerovate Therapeutics0.4518 of 5 stars$2.59-1.1%$2.25-13.1%-88.5%$74.80MN/A-0.8720Short Interest ↑ENTXEntera Bio3.1359 of 5 stars$2.09-4.6%$10.00+378.5%+163.3%$74.78M$130,000.00-8.0420Short Interest ↓Positive News Related Companies and Tools Related Companies ZIVO Bioscience Competitors Karyopharm Therapeutics Competitors Rani Therapeutics Competitors I-Mab Competitors Assertio Competitors Galectin Therapeutics Competitors Adlai Nortye Competitors ESSA Pharma Competitors Aerovate Therapeutics Competitors Entera Bio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BFRG) was last updated on 2/12/2025 by MarketBeat.com Staff From Our PartnersIs this Elon’s true agenda?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | SponsoredTrump Set to Trigger Next AI Boom by February 26?President Trump recently announced this shocking $500 billion initiative to build 20 new AI factories… And ...Brownstone Research | Sponsored$589 billion wiped out overnightYou need to watch this before you invest another cent in AI. Because more than $589 billion was wiped out o...Porter & Company | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.